You can buy or sell NAVB and other stocks, options, ETFs, and crypto commission-free!
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. Read More The company was founded in 1983 and is headquartered in Dublin, OH.
52 Week High
52 Week Low
Yahoo FinanceMay 11
Edited Transcript of NAVB earnings conference call or presentation 8-May-19 9:00pm GMT
Q1 2019 Navidea Biopharmaceuticals Inc Earnings Call DUBLIN May 12, 2019 (Thomson StreetEvents) -- Edited Transcript of Navidea Biopharmaceuticals Inc earnings conference call or presentation Wednesday, May 8, 2019 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Erika Gibson Navidea Biopharmaceuticals, Inc. - Director of...
Yahoo FinanceMay 8
Navidea Biopharmaceuticals Reports First Quarter 2019 Financial Results
DUBLIN, Ohio--(BUSINESS WIRE)-- Conference Call to be held Wednesday, May 8, 2019 at 5:00 pm ET Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the first quarter of 2019. Navidea reported total revenues for the quarter of $136,000. Net loss attributable to common stockholders was $2.4 million. “During the first quarter, Navidea re...
Yahoo FinanceMay 1
Navidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update
DUBLIN, Ohio--(BUSINESS WIRE)-- Conference Call to be held Wednesday, May 8, 2019 at 5:00 p.m. (EDT) Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on Wednesday, May 8, 2019 at 5:00 p.m. (EDT) to discuss its financial results for the first quarter of 2019. Jed Latkin, Chief Executive Officer, Erika Gibson, Direct...
Expected Aug 7, After Hours